# Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/subcutaneous-versus-intravenous-amivantamab-both-in-combination-with-lazertinib/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Natasha B. Leighl,Hiroaki Akamatsu,Sun Min Lim,Ying Cheng,Anna Minchom,Melina E. Marmarelis,Rachel E. Sanborn,James Chih‐Hsin Yang,Baogang Liu,Thomas John,Bartomeu Massutí,Alexander I. Spira,Se‐Hoon Lee,Jialei Wang,Juan Li,Caigang Liu,Silvia Novello,Masashi Kondo,Motohiro Tamiya,Ernesto Korbenfeld,Mor Moskovitz,Ji‐Youn Han,Mariam P. Alexander,Rohit Joshi,Enriqueta Felip,Pei Jye Voon,Pongwut Danchaivijitr,Ping‐Chih Hsu,Felipe José Silva Melo Cruz,Thomas Wehler,Laurent Greillier,Encarnação Teixeira,Danny Nguyen,Joshua K. Sabari,Angel Qin,Dariusz M. Kowalski,Mehmet Alı Nahıt Şendur,John Xie,Debopriya Ghosh,Ali Alhadab,Nahor Haddish‐Berhane,Pamela L. Clemens,Patricia Lorenzini,Remy B. Verheijen,Mohamed Gamil,Joshua Bauml,Mahadi Baig,Antonio Passaro,for the PALOMA-3 Investigators,Hiroaki Akamatsu,Mariam P. Alexander,Annalen Bleckmann,Federico Cappuzzo,Ying Cheng,Byoung Chul Cho,Timuçin Çil,Alexis B. Cortot,Pongwut Danchaivijitr,Till‐Oliver Emde,Dilek Erdem,Enriqueta Felip,F. Estevinho,Maria Lurdes Ferreira,Flavio Ferreira da Silva,Maria Campelo,Laurent Greillier,Alastair Greystoke,Ji‐Youn Han,Ping‐Chih Hsu,Jen‐Yu Hung,Mei Ji,Thomas John,Rohit Joshi,Young‐Chul Kim,Masashi Kondo,Ernesto Korbenfeld,Dariusz M. Kowalski,Se‐Hoon Lee,Natasha B. Leighl,Juan Li,Sheng-Hao Lin,Baogang Liu,Caigang Liu,John Seng-Hooi Low,Melina E. Marmarelis,Bartomeu Massutí,Anna R. Minchom,Sara Moore,Mor Moskovitz,Adnan Nagrial,Danny Nguyen,Silvia Novello,Y. Ohe,Mustafa Özgüroğlu,Özgür Özyılkan,Antonio Passaro,Nir Peled,Naiyarat Prasongsook,Angel Qin,Elisa F. Ramos |
| Citations | 123 |
| DOI | 10.1200/jco.24.01001 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1200/jco.24.01001 |
| OpenAlex ID | https://openalex.org/W4399480368 |
| PMID | 38857463 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Damien Urban](https://scholariq.org/researchers/damien-urban/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.